(panels A and C) and between the overall control population, relatives who did not progress after three years follow-up (non-progressors) and those who developed diabetes within 3-years (progressors) (panels B and D). AUC: area under the curve; 95%CI: 95% confidence interval; OGTT: oral glucose tolerance test; FBG: fasting blood glucose; 2h PG: two-hour post load plasma glucose level during OGTT; C-peptide AUC 5-10 min : C-peptide release during the first-phase (5-10 min) of hyperglycemic clamp; Cpeptide AUC 120-150 min : C-peptide release during the second-phase (120-150 min) of hyperglycemic clamp, calculations were done in 56 study participants with complete data among whom 9 developed diabetes within 3 years; a best combination of a single OGTT-derived marker and AUC 5-10min , b best combination of a single OGTT-derived marker and AUC 120-150min, data resulting from the analysis of 9 progressors among 56 relatives aged 12-39 years with complete dataset. 
